@lmmonsignore
#Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival: https://t.co/y3PW1ERj1s #cancer #irad @PennRadiology @UCSDHealth @UCSF_IR @KristenStashek https://t.co/bTXRKV8OCR
RT @PennRadiology: Proud to see IR Fellow Dr. Chen's and colleagues' work contributing to the care of cancer patients. #embolotherapy #neur…
RT @CVIR_Journal: Congratulations to James X. Chen et al - winners of the CVIR award for most cited article in 2017: https://t.co/8UGMzzyEC…
RT @Watts_IR: Brilliant IR, great guy. Well deserved! I’m excited to watch his career continue to develop. Keep an eye on him @LessneVIR 👀…
RT @PennRadiology: Proud to see IR Fellow Dr. Chen's and colleagues' work contributing to the care of cancer patients. #embolotherapy #neur…
Proud to see IR Fellow Dr. Chen's and colleagues' work contributing to the care of cancer patients. #embolotherapy #neuroendocrinetumor
Brilliant IR, great guy. Well deserved! I’m excited to watch his career continue to develop. Keep an eye on him @LessneVIR 👀
RT @CVIR_Journal: Congratulations to James X. Chen et al - winners of the CVIR award for most cited article in 2017: https://t.co/8UGMzzyEC…
RT @CVIR_Journal: Congratulations to James X. Chen et al - winners of the CVIR award for most cited article in 2017: https://t.co/8UGMzzyEC…
Congratulations to James X. Chen et al - winners of the CVIR award for most cited article in 2017: https://t.co/8UGMzzyEC0 @PennMedicine @UCSDHealth @MedicalCollege @PennRadiology @MoffittNews @UCSF_IR #justglueit https://t.co/y8QwrKoqjw
RT @CVIR_Journal: Any significant differences among embolotherapy modalities when treating neuroendocrine tumor liver metastases? https://t…
RT @CVIR_Journal: Any significant differences among embolotherapy modalities when treating neuroendocrine tumor liver metastases? https://t…
RT @CVIR_Journal: Any significant differences among embolotherapy modalities when treating neuroendocrine tumor liver metastases? https://t…
RT @CVIR_Journal: Any significant differences among embolotherapy modalities when treating neuroendocrine tumor liver metastases? https://t…
Any significant differences among embolotherapy modalities when treating neuroendocrine tumor liver metastases? https://t.co/Kl25UZWHO9